Glioma: all 1,425 studies
Page 10 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and GliomasNo longer availableNCT03460782
- Nurse-led Family and Network ConsultationsCompletedNCT03458312Not applicable
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasStatus unknownNCT03423992Phase 1
- ONC201 in Pediatric H3 K27M GliomasTerminatedNCT03416530Phase 1
- IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade GliomaCompletedNCT03407781Phase 1
- Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)Status unknownNCT03392545Phase 1
- A Study of Apatinib in Recurrent or Recurrent High-grade GliomaStatus unknownNCT03390062Phase 2
- Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV GliomaActive, not recruitingNCT03389230Phase 1
- Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.Active, not recruitingNCT03363217Phase 2
- A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)CompletedNCT03355794Phase 1
- Study of AG-120 and AG-881 in Subjects With Low Grade GliomaCompletedNCT03343197Phase 1
- 68Ga-citrate PET/MR Imaging for GliomaTerminatedNCT03335280
- Intermittent Dosing Of Selumetinib In Childhood NF1 Associated TumoursCompletedNCT03326388Phase 1/2
- Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working MemoryCompletedNCT03323450Not applicable
- ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating GliomaSuspendedNCT03322813Not applicable
- Expanded Access for Pembrolizumab (MK-3475)No longer availableNCT03311542
- PEP-CMV in Recurrent MEdulloblastoma/Malignant GliomaActive, not recruitingNCT03299309Phase 1
- Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of GlioblastomaWithdrawnNCT03275558Phase 1
- Evaluation of Cerebral Elastography by Magnetic Resonance: Comparison of Healthy Subjects and Patients With Glial TumorStatus unknownNCT03274037Not applicable
- Quality of Life and Neurocognitive FunctioningCompletedNCT03257618Not applicable
- CAR-T Cell Immunotherapy for GD2 Positive Glioma PatientsWithdrawnNCT03252171Phase 1/2
- Rare CNS Tumors Outcomes &RiskCompletedNCT03251989
- Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-CaCompletedNCT03250520Early Phase 1
- Mind-Body Intervention in Glioma CouplesActive, not recruitingNCT03244995Not applicable
- International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)Status unknownNCT03243461Phase 3
- Simultaneous Integrated Boost in Malignant Glioma Patients Treated With ChemoradiationStatus unknownNCT03225300Not applicable
- Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas PatientsActive, not recruitingNCT03212742Phase 1/2
- Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic BiopsyWithdrawnNCT03193463Early Phase 1
- Glioma Microenvironment an Exploratory StudyActive, not recruitingNCT03189420
- The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant GliomasStatus unknownNCT03180697
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaActive, not recruitingNCT03180502Phase 2
- Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine GliomasCompletedNCT03178032Phase 1
- LITT Palliative Treatment for Patients With Malignant GliomasWithdrawnNCT03176160
- Chronic Convection Enhanced Delivery of TopotecanCompletedNCT03154996Phase 1
- A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Active, not recruitingNCT03152318Phase 1
- VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMTerminatedNCT03149575Phase 3
- Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade GliomasNo longer availableNCT03134131
- Re-Irradiation of Progressive or Recurrent DIPGCompletedNCT03126266Not applicable
- Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR ImagingStatus unknownNCT03102203
- Noninvasively Predicting Gene Status of GliomaStatus unknownNCT03102112
- ZOOMit-fMRI Identifies Motor Functional CortexStatus unknownNCT03091270
- CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)CompletedNCT03086616Phase 1
- Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical TrialCompletedNCT03082846Not applicable
- The Research on 89Zr-ABT806 PET Imaging in High Grade GliomaStatus unknownNCT03058198Not applicable
- Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT ExpressionCompletedNCT03050736Phase 2
- Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPGActive, not recruitingNCT03033992Not applicable
- Study of DS-1001b in Patients With Gene IDH1-Mutated GliomasCompletedNCT03030066Phase 1
- MRS and 11C-methionine PET/CT in the Diagnosis of GliomaCompletedNCT03009318Not applicable
- Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine GliomaCompletedNCT02992015Early Phase 1
- Phase 2 Study of IDH305 in Low Grade GliomasWithdrawnNCT02987010Phase 2
- [11C]Acetate PET in Patients With GliomaTerminatedNCT02986815Not applicable
- Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade GliomasCompletedNCT02978261Phase 1
- Trial of IDH305 in IDH1 Mutant Grade II or III GliomaWithdrawnNCT02977689Phase 2
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade GliomasWithdrawnNCT02976441Early Phase 1
- Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With GliomaCompletedNCT02971319Phase 2
- Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade GliomasCompletedNCT02970448Early Phase 1
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application StudyStatus unknownNCT02941302Not applicable
- MR Perfusion Methods in Patients With Suspected Recurrent High Grade GliomasCompletedNCT02919865Not applicable
- Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain CancerCompletedNCT02903069Phase 1
- Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and OverCompletedNCT02892708Phase 3
- Cerebral Bases Bodily RepresentationsStatus unknownNCT02876016Not applicable
- Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant GliomaCompletedNCT02861222Phase 1
- Study of the Anti-tumoral Immune ResponseCompletedNCT02854644Not applicable
- Natural History of and Specimen Banking for People With Tumors of the Central Nervous SystemCompletedNCT02851706
- Apatinib and Irinotecan in Treating Patients With Recurrent High-grade GliomaStatus unknownNCT02848794Phase 1/2
- Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)Active, not recruitingNCT02840409Phase 2
- Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor LinesStatus unknownNCT02840123Phase 1
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2
- Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade GliomaTerminatedNCT02833701Phase 1
- Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade GliomasCompletedNCT02829931Phase 1
- Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma GliomasStatus unknownNCT02795364Not applicable
- Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor PatientsTerminatedNCT02783495Not applicable
- Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)Status unknownNCT02772094Phase 2
- Safety and Efficacy of IDH1R132H-DC Vaccine in GliomasStatus unknownNCT02771301Not applicable
- CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III GliomasStatus unknownNCT02766270Early Phase 1
- Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine GliomaTerminatedNCT02758366Phase 2
- The Impact of Anesthesia on High- Grade Glioma PatientsStatus unknownNCT02756312Not applicable
- A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade GliomasCompletedNCT02750891Phase 1/2
- Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain TumorsCompletedNCT02747407
- Clinical Development of MR Spectroscopy and Imaging in Brain CancersCompletedNCT02731521
- Assessing Psychosocial and Supportive Care Needs in Patients With GliomasCompletedNCT02728024
- Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent SettingCompletedNCT02717962Phase 2
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerActive, not recruitingNCT02691923Phase 2
- Supratotal Resection for Gliomas Within Noneloquent AreasStatus unknownNCT02676687Not applicable
- Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade GliomasTerminatedNCT02659800Phase 1
- Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator PhenotypeActive, not recruitingNCT02658279Not applicable
- Hemostasis Alterations in Neurosurgical PatientsStatus unknownNCT02652897
- Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
- Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant TumorCompletedNCT02632370
- A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant GliomasStatus unknownNCT02629757Phase 3
- Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI TechniquesStatus unknownNCT02622620
- CAR-T Cell Immunotherapy in MUC1 Positive Solid TumorStatus unknownNCT02617134Phase 1/2
- ROCOCO - Low Grade Glioma - Planning StudyCompletedNCT02607397
- A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of CareWithdrawnNCT02598011Phase 1
- Non Invasive Detection of IDH1/2 Mutation in GliomasStatus unknownNCT02597335Not applicable
- Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaCompletedNCT02590263Phase 1/2